These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 31481274

  • 21. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
    Kanda M, Koike M, Shimizu D, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Omae K, Yamada S, Nakayama G, Kodera Y.
    Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
    [Abstract] [Full Text] [Related]

  • 22. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG.
    J Clin Oncol; 2005 Mar 01; 23(7):1455-62. PubMed ID: 15735121
    [Abstract] [Full Text] [Related]

  • 23. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
    Guo HT, Bi XH, Lei T, Lv X, Yao G, Chen Y, Liu C.
    BMC Cancer; 2020 May 19; 20(1):441. PubMed ID: 32429859
    [Abstract] [Full Text] [Related]

  • 24. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
    Luan XM, Zhang Y, Wang SZ, Wang N, Li W, Zhang Q, Wei H, Zhang SL.
    Zhonghua Yi Xue Za Zhi; 2012 May 22; 92(19):1330-3. PubMed ID: 22883121
    [Abstract] [Full Text] [Related]

  • 25. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix.
    Strauss HG, Laban C, Lautenschläger C, Buchmann J, Schneider I, Koelbl H.
    Eur J Cancer; 2002 Oct 22; 38(15):1987-91. PubMed ID: 12376202
    [Abstract] [Full Text] [Related]

  • 26. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
    Ogino I, Nakayama H, Okamoto N, Kitamura T, Inoue T.
    Int J Gynecol Cancer; 2006 Oct 22; 16(3):1094-100. PubMed ID: 16803491
    [Abstract] [Full Text] [Related]

  • 27. Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinoma.
    Wan Q, Yan W, Liu Y, Lin Y, Lu Z.
    Cancer Biomark; 2020 Oct 22; 29(3):327-335. PubMed ID: 32716344
    [Abstract] [Full Text] [Related]

  • 28. Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study.
    Harima Y, Ariga T, Kaneyasu Y, Ikushima H, Tokumaru S, Shimamoto S, Takahashi T, Ii N, Tsujino K, Saito AI, Ushijima H, Toita T, Ohno T.
    PLoS One; 2021 Oct 22; 16(11):e0259235. PubMed ID: 34727105
    [Abstract] [Full Text] [Related]

  • 29. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
    Huang SF, Wei FC, Liao CT, Wang HM, Lin CY, Lo S, Huang JJ, Chen IH, Kang CJ, Chien HT, Chen HH.
    Ann Surg Oncol; 2012 Nov 22; 19(12):3856-64. PubMed ID: 22576068
    [Abstract] [Full Text] [Related]

  • 30. The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study.
    Ye S, Sun X, Kang B, Wu F, Zheng Z, Xiang L, Lesénéchal M, Heskia F, Liang J, Yang H.
    BMC Cancer; 2020 Feb 21; 20(1):138. PubMed ID: 32085736
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB.
    Gynecol Oncol; 2000 Apr 21; 77(1):164-70. PubMed ID: 10739706
    [Abstract] [Full Text] [Related]

  • 33. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
    van de Lande J, Davelaar EM, von Mensdorff-Pouilly S, Water TJ, Berkhof J, van Baal WM, Kenemans P, Verheijen RH.
    Gynecol Oncol; 2009 Jan 21; 112(1):119-25. PubMed ID: 19007978
    [Abstract] [Full Text] [Related]

  • 34. Study on the preoperative value of serum SCC-Ag in predicting the stromal invasion of cervical squamous cell carcinoma.
    Qin L.
    J Cancer Res Clin Oncol; 2023 Sep 21; 149(11):9167-9171. PubMed ID: 37184678
    [Abstract] [Full Text] [Related]

  • 35. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis.
    Yuan CC, Wang PH, Ng HT, Tsai LC, Juang CM, Chiu LM.
    Eur J Gynaecol Oncol; 2002 Sep 21; 23(1):17-20. PubMed ID: 11876385
    [Abstract] [Full Text] [Related]

  • 36. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
    Ogino I, Nakayama H, Kitamura T, Okamoto N, Inoue T.
    Int J Gynecol Cancer; 2005 Sep 21; 15(4):630-8. PubMed ID: 16014117
    [Abstract] [Full Text] [Related]

  • 37. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
    Gaarenstroom KN, Bonfrer JM, Kenter GG, Korse CM, Hart AA, Trimbos JB, Helmerhorst TJ.
    Cancer; 1995 Sep 01; 76(5):807-13. PubMed ID: 8625184
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Huang YJ, Chanchien CC, Lin H, Wang CJ, Sun LM, Tseng CW, Tsai CC, Ou YC, Fu HC, Chen HC, Hsu HC, Wang CY.
    Radiat Oncol; 2012 Jan 30; 7():13. PubMed ID: 22289572
    [Abstract] [Full Text] [Related]

  • 40. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
    Olsen JR, Dehdashti F, Siegel BA, Zighelboim I, Grigsby PW, Schwarz JK.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):772-7. PubMed ID: 20888130
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.